Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 943K 877K 805K 1.51M 103M 1.54M 10.41M 4.07M 50.83M 4.03M 3.94M 176M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 726K 675K 620K 1.16M 79.61M 1.18M 8.02M 3.13M 39.14M 3.1M 3.04M 135M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 day+0.14%
6 months+133.33%
Current year+133.33%
1 week 0
Extreme 0.0007
0
1 month 0
Extreme 0.0007
0
Current year 0
Extreme 0.0004
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.03
5 years 0
Extreme 0
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 26/06/2019
Director TitleAgeSince
Director/Board Member 64 01/01/2003
Director/Board Member 84 01/01/2005
Director/Board Member - 01/03/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%0.00%+600.00%-96.83% 26.4K
+0.03%-3.08%-25.70%+13.01% 2,835B
-0.36%-7.15%-22.59%+648.14% 295B
-1.92%+2.89%+171.09%+977.35% 114B
-1.28%-1.17%-1.79%+39.44% 89.98B
+1.01%-4.57%+64.75%+123.12% 87.87B
-0.01%-2.81%-37.92%-16.88% 71.51B
+0.50%-3.89%-36.59%+62.07% 61.25B
+0.61%-2.13%+3.07%+54.18% 43.01B
0.00%-7.99%-59.98%+19.02% 34.04B
Average -0.13%-3.15%+65.43%+182.26% 363.14B
Weighted average by Cap. -0.06%-3.30%-16.91%+98.83%

Financials

2015 2016
Net sales 4.22M 3.71M 3.45M 3.16M 5.95M 407M 6.04M 40.95M 16M 200M 15.85M 15.51M 691M 3.04M 2.67M 2.49M 2.28M 4.29M 293M 4.35M 29.53M 11.54M 144M 11.43M 11.18M 498M
Net income 151K 133K 123K 113K 213K 14.54M 216K 1.46M 572K 7.15M 567K 555K 24.72M -344K -302K -281K -258K -484K -33.13M -492K -3.34M -1.3M -16.29M -1.29M -1.26M -56.31M
Net Debt -340K -299K -278K -255K -479K -32.74M -486K -3.3M -1.29M -16.1M -1.28M -1.25M -55.66M -247K -217K -202K -185K -348K -23.79M -353K -2.4M -936K -11.69M -927K -907K -40.43M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. NMXS Stock